172 related articles for article (PubMed ID: 32476944)
1. Systemic glucocorticoids plus cyclophosphamide for acute exacerbation of idiopathic pulmonary fibrosis: a retrospective nationwide study.
Aso S; Matsui H; Fushimi K; Yasunaga H
Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(2):116-123. PubMed ID: 32476944
[TBL] [Abstract][Full Text] [Related]
2. Corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: a single center experience and literature review.
Novelli L; Ruggiero R; De Giacomi F; Biffi A; Faverio P; Bilucaglia L; Gamberini S; Messinesi G; Pesci A
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):385-391. PubMed ID: 28079851
[TBL] [Abstract][Full Text] [Related]
3. Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial.
Naccache JM; Jouneau S; Didier M; Borie R; Cachanado M; Bourdin A; Reynaud-Gaubert M; Bonniaud P; Israël-Biet D; Prévot G; Hirschi S; Lebargy F; Marchand-Adam S; Bautin N; Traclet J; Gomez E; Leroy S; Gagnadoux F; Rivière F; Bergot E; Gondouin A; Blanchard E; Parrot A; Blanc FX; Chabrol A; Dominique S; Gibelin A; Tazi A; Berard L; Brillet PY; Debray MP; Rousseau A; Kerjouan M; Freynet O; Dombret MC; Gamez AS; Nieves A; Beltramo G; Pastré J; Le Borgne-Krams A; Dégot T; Launois C; Plantier L; Wémeau-Stervinou L; Cadranel J; Chenivesse C; Valeyre D; Crestani B; Cottin V; Simon T; Nunes H;
Lancet Respir Med; 2022 Jan; 10(1):26-34. PubMed ID: 34506761
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of corticosteroid and intravenous cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A propensity score-matched analysis.
Hozumi H; Hasegawa H; Miyashita K; Yasui H; Suzuki Y; Kono M; Karayama M; Furuhashi K; Hashimoto D; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Yokomura K; Nakamura H; Suda T
Respirology; 2019 Aug; 24(8):792-798. PubMed ID: 30803100
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus and steroid treatment for acute exacerbation of idiopathic pulmonary fibrosis.
Horita N; Akahane M; Okada Y; Kobayashi Y; Arai T; Amano I; Takezawa T; To M; To Y
Intern Med; 2011; 50(3):189-95. PubMed ID: 21297319
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of combined corticosteroid and pirfenidone for acute exacerbation of idiopathic pulmonary fibrosis after surgery for lung cancer: a case report.
Ohkubo H; Kunii E; Moriyama S; Niimi A
Respir Investig; 2015 Jan; 53(1):45-7. PubMed ID: 25542603
[No Abstract] [Full Text] [Related]
7. Efficacy of concurrent treatments in idiopathic pulmonary fibrosis patients with a rapid progression of respiratory failure: an analysis of a national administrative database in Japan.
Oda K; Yatera K; Fujino Y; Ishimoto H; Nakao H; Hanaka T; Ogoshi T; Kido T; Fushimi K; Matsuda S; Mukae H
BMC Pulm Med; 2016 Jun; 16(1):91. PubMed ID: 27278093
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporin A followed by the treatment of acute exacerbation of idiopathic pulmonary fibrosis with corticosteroid.
Inase N; Sawada M; Ohtani Y; Miyake S; Isogai S; Sakashita H; Miyazaki Y; Yoshizawa Y
Intern Med; 2003 Jul; 42(7):565-70. PubMed ID: 12879947
[TBL] [Abstract][Full Text] [Related]
9. Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP).
Naccache JM; Montil M; Cadranel J; Cachanado M; Cottin V; Crestani B; Valeyre D; Wallaert B; Simon T; Nunes H
BMC Pulm Med; 2019 Apr; 19(1):75. PubMed ID: 30971235
[TBL] [Abstract][Full Text] [Related]
10. Acute exacerbation of idiopathic pulmonary fibrosis: outcome and prognostic factors.
Simon-Blancal V; Freynet O; Nunes H; Bouvry D; Naggara N; Brillet PY; Denis D; Cohen Y; Vincent F; Valeyre D; Naccache JM
Respiration; 2012; 83(1):28-35. PubMed ID: 21860222
[TBL] [Abstract][Full Text] [Related]
11. Effect of cyclosporine A on mortality after acute exacerbation of idiopathic pulmonary fibrosis.
Aso S; Matsui H; Fushimi K; Yasunaga H
J Thorac Dis; 2018 Sep; 10(9):5275-5282. PubMed ID: 30416775
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for an acute exacerbation of idiopathic pulmonary fibrosis.
Kakugawa T; Sakamoto N; Sato S; Yura H; Harada T; Nakashima S; Hara A; Oda K; Ishimoto H; Yatera K; Ishimatsu Y; Obase Y; Kohno S; Mukae H
Respir Res; 2016 Jul; 17(1):79. PubMed ID: 27401332
[TBL] [Abstract][Full Text] [Related]
13. Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients.
Feng H; Zhao Y; Li Z; Kang J
Ther Adv Respir Dis; 2020; 14():1753466620963015. PubMed ID: 33070705
[TBL] [Abstract][Full Text] [Related]
14. Exacerbations of idiopathic pulmonary fibrosis treated with corticosteroids and cyclophosphamide pulses.
Morawiec E; Tillie-Leblond I; Pansini V; Salleron J; Remy-Jardin M; Wallaert B
Eur Respir J; 2011 Dec; 38(6):1487-9. PubMed ID: 22130770
[No Abstract] [Full Text] [Related]
15. Long-term efficacy of macrolide treatment in idiopathic pulmonary fibrosis: a retrospective analysis.
Kuse N; Abe S; Hayashi H; Kamio K; Saito Y; Usuki J; Azuma A; Kudoh S; Gemma A
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):242-246. PubMed ID: 27758989
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear.
Walsh M; Casian A; Flossmann O; Westman K; Höglund P; Pusey C; Jayne DR;
Kidney Int; 2013 Aug; 84(2):397-402. PubMed ID: 23615499
[TBL] [Abstract][Full Text] [Related]
17. Staging of acute exacerbation in patients with idiopathic pulmonary fibrosis.
Kishaba T; Tamaki H; Shimaoka Y; Fukuyama H; Yamashiro S
Lung; 2014 Feb; 192(1):141-9. PubMed ID: 24221341
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of low-dose glucocorticoid regimen in association with cyclophosphamide in patients with glomerulonephritis.
Hirja AR; Voroneanu L; Siriopol D; Nistor I; Hogas S; Apetrii M; Volovat C; Veisa G; Mititiuc IL; Florea L; Onofriescu M; Covic A
Int Urol Nephrol; 2019 Oct; 51(10):1805-1813. PubMed ID: 31385176
[TBL] [Abstract][Full Text] [Related]
19. Intensified, intermittent, low-dose intravenous cyclophosphamide together with oral alternate-day steroid therapy in lupus nephritis (long-term outcome).
Calguneri M; Ozbalkan Z; Ozturk MA; Apras S; Ertenli AI; Kiraz S
Clin Rheumatol; 2006 Nov; 25(6):782-8. PubMed ID: 16547692
[TBL] [Abstract][Full Text] [Related]
20. An Acute Exacerbation of Idiopathic Pulmonary Fibrosis After BNT162b2 mRNA COVID-19 Vaccination: A Case Report.
Ghincea A; Ryu C; Herzog EL
Chest; 2022 Feb; 161(2):e71-e73. PubMed ID: 35131075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
